|
|
|
|
||
Re: Pricing/Valuation It's imperative that management seek a P4 for oncology ASAP upon approval - there is no reason for a catheter to need an additional trial just for a different use. Four years ago I put my numbers out there and people laughed - the vial price is now significantly higher than my assumption but oncology is still the gold mine. Thanks for running the numbers! HAB |
return to message board, top of board |